Related Experiment Video
Updated: Aug 9, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
[Omega-3 fatty acids and cardiovascular diseases]
1Service d'Endocrinologie, C.H.U. de Charleroi.
Insights
Omega-3 fatty acids may reduce cardiovascular risk, particularly for post-myocardial infarction patients. However, evidence from Cochrane reviews is inconclusive regarding overall benefits for all subjects.
Area of Science:
- Cardiovascular health and nutrition science.
- Investigates the role of omega-3 fatty acids in cardiovascular disease prevention and management.
Context:
- Epidemiological studies suggest omega-3 intake reduces cardiovascular risk.
- Some intervention trials indicate reduced sudden death post-myocardial infarction.
- Evidence synthesis from Cochrane Library reviews presents conflicting conclusions.
Purpose:
- To evaluate the overall efficacy of omega-3 supplementation for cardiovascular risk reduction.
- To determine specific patient groups that may benefit from omega-3 intake.
Summary:
- While many studies link omega-3 intake to lower cardiovascular risk, robust evidence from systematic reviews is lacking.
- A potential benefit is observed for omega-3 supplementation in patients recovering from myocardial infarction.
Impact:
- Omega-3 supplementation might be a beneficial addition to standard therapies for post-myocardial infarction patients.
- Further research may clarify the precise role and optimal use of omega-3s in cardiovascular care.
Abstract:
Most--but not all--epidemiological studies have demonstrated that omega-3 intake, either from nutrition or supplementation, reduces cardiovascular risk. A few intervention studies have shown a reduction of studden death in patients followed after a myocardial infarction. However EBM studies from the Cochrane Library do not confirm the real advantage of omega-3 in any group of subjects. Probably, the most interesting prescription of omega-3 supplementations would benefit to the patients after myocardial infarction, in addition to drugs that have proved their efficacy (aspirine, beta-blocker statin and ACE inhibitor).
Related Concept Videos
Atherosclerosis III: Management
Structure of Lipids
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Lipids: Dietary Sources and Requirements
Coronary Artery Disease IV: Preventive Measures